Skip Navigation



JAC Advance Access published online on June 5, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm194
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/2/440    most recent
dkm194v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kanerva, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanerva, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Antimicrobial use in Finnish acute care hospitals: data from national prevalence survey, 2005

Mari Kanerva1,2,*, Jukka Ollgren1, Outi Lyytikäinen on behalf of the Finnish Prevalence Survey Study Group1

1 Finnish Hospital Infection Program (SIRO), National Public Health Institute, Department of Infectious Disease Epidemiology, Helsinki, Finland 2 Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

Received 2 March 2007; returned 5 April 2007; revised 27 April 2007; accepted 6 May 2007


* Correspondence address. Helsinki University Central Hospital, Department of Medicine, Division of Infectious Diseases, Meilahti Hospital, 2nd Floor, PO Box 340, FIN-00029 HUS, Finland. Tel: +358-504272155; Fax: +358-947171485; E-mail: mari.kanerva{at}hus.fi

Objectives: In Finland, use of antimicrobials in ambulatory care is moderate, but some reports suggest that hospital use is higher than in other European countries. We evaluated the amount and type of antimicrobials administered in Finnish acute care hospitals.

Patients and methods: We analysed data collected in the national prevalence survey of nosocomial infections (NIs) during February–March 2005 in all tertiary care, all secondary care and 25% of other acute care hospitals. All inpatients present on the study day in acute care wards for adults were included (n = 8234). The names and use-days of antimicrobials in Anatomical Therapeutic Class groups J01–J05 were collected on the study day and retrospectively for the previous 6 days.

Results: On the study day, 39% of patients had received at least one, 14% at least two and 3% at least three antimicrobials; patients with NI represented 21%, 29% and 45% of these groups, respectively. The prevalence of patients receiving any antimicrobial was 53% in intensive care patients and varied in other specialties from 0% in ophthalmology to 63% in dental and oral surgery. Within a 7 day period, the total use of antibacterial agents (J01) was 64 use-days per 100 patient-days. Cephalosporins were the most frequently used antimicrobials, followed by quinolones and metronidazole.

Conclusions: The prevalence and spectrum of antimicrobial use in Finnish acute care hospitals were high. NI patients contributed markedly to the total usage. The NI survey with a 7 day data collection period provided insights into the use-density of antimicrobials.

Key Words: antibiotic use , drug consumption , nosocomial infection , Finland


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.